Literature DB >> 21414785

The female breast and diabetes.

Evanthia Gouveri1, Nikolaos Papanas, Efstratios Maltezos.   

Abstract

The present review outlines the various issues of breast pathology in diabetes. Diabetic mastopathy is an uncommon proliferation of fibrous tissue in the breast that mimics tumour. Breast arterial calcifications represent calcium deposits in the media of arterioles and are more frequently detected on mammograms of diabetic subjects. Importantly, type 2 diabetes mellitus (T2DM) has been associated with breast cancer, but the mechanism underlying this association is complex, since the two entities frequently co-exist and seem to share common aetiological factors and pathways. Furthermore, diabetes has been suggested to negatively affect breast cancer outcomes, but it is unclear whether better glycaemic control would ameliorate prognosis. Preliminary data suggest that antidiabetic treatment may also influence both the incidence and prognosis of breast cancer. However, available evidence is inconclusive and further research is needed. Therefore, treatment of diabetes should not be determined by its potential effect on breast cancer.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21414785     DOI: 10.1016/j.breast.2011.02.019

Source DB:  PubMed          Journal:  Breast        ISSN: 0960-9776            Impact factor:   4.380


  10 in total

1.  Clinicopathologic features of breast cancer patients with type 2 diabetes mellitus in southwest of China.

Authors:  Rui-Jue Wang; Lin-Jie Lu; Liang-Bin Jin; Hong-Yuan Li; Guo-Sheng Ren; Kai-Nan Wu; Sheng-Chun Liu; Ling-Quan Kong
Journal:  Med Oncol       Date:  2013-12-12       Impact factor: 3.064

2.  Metformin and thiazolidinediones are associated with improved breast cancer-specific survival of diabetic women with HER2+ breast cancer.

Authors:  X He; F J Esteva; J Ensor; G N Hortobagyi; M-H Lee; S-C J Yeung
Journal:  Ann Oncol       Date:  2011-11-22       Impact factor: 32.976

3.  Effect of Metformin Therapy on Biological Properties and Prognosis of Breast Cancer Patients Complicated with Type-2 Diabetes.

Authors:  Xiaolu Yan; Zhe Gao; Yang Li; Qingxia Li; Xinna Deng
Journal:  Pak J Med Sci       Date:  2022 May-Jun       Impact factor: 2.340

4.  Understanding the Association of Type 2 Diabetes Mellitus in Breast Cancer Among African American and European American Populations in South Carolina.

Authors:  Marsha E Samson; Swann Arp Adams; Olubunmi Orekoya; James R Hebert
Journal:  J Racial Ethn Health Disparities       Date:  2015-10-20

5.  Radiological findings of breast involvement in benign and malignant systemic diseases.

Authors:  Renato Augusto Eidy Kiota Matsumoto; Juliana Hiraoka Catani; Mirela Liberato Campoy; Arthur Magalhães Oliveira; Nestor de Barros
Journal:  Radiol Bras       Date:  2018 Sep-Oct

6.  Prevalent diabetes and risk of total, colorectal, prostate and breast cancers in an ageing population: meta-analysis of individual participant data from cohorts of the CHANCES consortium.

Authors:  Amina Amadou; Heinz Freisling; Mazda Jenab; Konstantinos K Tsilidis; Antonia Trichopoulou; Paolo Boffetta; Bethany Van Guelpen; Olatz Mokoroa; Tom Wilsgaard; Frank Kee; Ben Schöttker; José M Ordóñez-Mena; Satu Männistö; Stefan Söderberg; Roel C H Vermeulen; J Ramón Quirós; Linda M Liao; Rashmi Sinha; Kari Kuulasmaa; Hermann Brenner; Isabelle Romieu
Journal:  Br J Cancer       Date:  2021-03-26       Impact factor: 7.640

7.  Breast manifestations of systemic diseases.

Authors:  Christina A Dilaveri; Maire Brid Mac Bride; Nicole P Sandhu; Lonzetta Neal; Karthik Ghosh; Dietlind L Wahner-Roedler
Journal:  Int J Womens Health       Date:  2012-02-07

Review 8.  Type 2 Diabetes and Breast Cancer: The Interplay between Impaired Glucose Metabolism and Oxidant Stress.

Authors:  Patrizia Ferroni; Silvia Riondino; Oreste Buonomo; Raffaele Palmirotta; Fiorella Guadagni; Mario Roselli
Journal:  Oxid Med Cell Longev       Date:  2015-06-11       Impact factor: 6.543

9.  Expressions of IGF-1R and Ki-67 in breast cancer patients with diabetes mellitus and an analysis of biological characteristics.

Authors:  Xiaolu Yan; Zhe Gao; Ye Zhou; Fei Gao; Qingxia Li
Journal:  Pak J Med Sci       Date:  2022 Jan-Feb       Impact factor: 1.088

Review 10.  Diabetes mellitus and prognosis in women with breast cancer: A systematic review and meta-analysis.

Authors:  Xiao-Bo Zhao; Guo-Sheng Ren
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.